Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Result of AGM

11 Jun 2015 12:00

RNS Number : 9155P
Plethora Solutions Holdings PLC
11 June 2015
 

Plethora Solutions Holdings PLC

("Plethora" or the "Company")

Result of Annual General Meeting

 

Plethora (AIM: PLE) announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were duly passed.

 

 

-Ends-

 

Plethora Solutions

Jamie Gibson, CEO

Mike Wyllie, CSO

 

Tel : +44(0) 20 3077 5400

finnCap (Nomad & Broker)

Geoff Nash/James Thompson

Stephen Norcross

Tel : +44(0) 20 7220 0500

(Corporate Finance)

(Corporate Broking)

Citigate Dewe Rogerson

David Dible

Malcolm Robertson

 

Tel: +44(0) 20 7282 2949

Tel: +44(0) 20 7282 2867

 

About Plethora

Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE LN). Further information is available at www.plethorasolutions.co.uk 

Plethora is focused on commercializing PSD502™ for the treatment of premature ejaculation with strategic marketing partners and obtaining NDA approval for PSD502™ with the FDA.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGUAVRRVOANAAR
Date   Source Headline
15th Mar 20132:57 pmRNSHolding(s) in Company
25th Feb 201311:07 amRNSStrategic review of The Urology Company Limited
14th Feb 20137:00 amRNSFinancing Update
5th Feb 201312:24 pmRNSRelated Party Transaction
5th Feb 20138:19 amRNSFinancing Update
7th Nov 20124:58 pmRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
29th Jun 201211:55 amRNSReport & Accounts
29th Jun 20127:00 amRNSTotal Voting Rights
26th Jun 20125:15 pmRNSHolding(s) in Company
15th Jun 20124:11 pmRNSIssue of Equity - Directors' Interest
14th Jun 201212:05 pmRNSSubscription of Shares
24th Apr 201212:00 pmRNSChange of Registered Office
29th Mar 20127:00 amRNSPreliminary Results
15th Mar 20127:00 amRNSPSD502 Regulatory Submission Update
23rd Jan 20127:01 amRNSTrading Statement
20th Jan 20127:00 amRNSProduct Launch
6th Jan 20127:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSProduct Update
31st Oct 20116:04 pmRNSTotal Voting Rights
14th Oct 20111:23 pmRNSResult of General Meeting
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSAmendment to PSD502 Agreements
28th Sep 20117:00 amRNSProposed Financing & Reduction of Debt
25th Jul 20117:00 amRNSStriant® SR commercial update
20th Jul 201112:09 pmRNSTrading Update
6th Jul 20111:24 pmRNSResult of AGM
24th Jun 20112:36 pmRNSReport and Accounts
20th Jun 20117:00 amRNSRe Agreement
9th Jun 201110:00 amRNSResignation of Dr Steven Powell
4th May 20117:00 amRNSExpansion of UK Sales Force
3rd May 20113:48 pmRNSTotal Voting Rights
28th Apr 20114:02 pmRNSDirector/PDMR Shareholding
28th Apr 20112:00 pmRNSHolding(s) in Company
20th Apr 20114:05 pmRNSResult of EGM
15th Apr 20117:00 amRNSHyalofemme Product Update
1st Apr 20117:00 amRNSPlacing
1st Apr 20117:00 amRNSFinal Results
14th Mar 20117:00 amRNSRe Agreement
11th Mar 20112:52 pmRNSDirectorate Change
24th Feb 201112:02 pmRNSHolding(s) in Company
3rd Feb 20119:48 amRNSDirector/PDMR Shareholding
3rd Feb 20117:00 amRNSTrading Update
28th Jan 20113:47 pmRNSHolding(s) in Company
22nd Dec 20104:42 pmRNSHolding(s) in Company
20th Dec 201010:24 amRNSResult of Meeting
20th Dec 20107:00 amRNSExpansion of Product Portfolio
3rd Dec 20107:05 amRNSBusiness Update & Proposed Placing
3rd Dec 20107:00 amRNSProduct Update
17th Nov 20107:01 amRNSLaunch of 3 New Products

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.